The acquisition was originally expected to close this month, but in November the DOJ sued to block the merger.

Amedisys Inc.’s (AMED) shares climbed 4.7% following news that the company extended the deadline to close its $3.3 billion merger plan with UnitedHealth Group Inc. (UNH). Shares of Lamb Weston ...

Amedisys' expected merger with UnitedHealth Group's Optum brings optimism to investors. Yet, a dull macroeconomic condition adds to the worry.

Warren Buffett has spent more than $70 million over six days to Dec. 24 to resume buying VeriSign's stock. Stronger-than-expected holiday cinema audiences brought North American box office totals to ...

According to a Securities Exchange Commission document filed by Amedisys on Friday, the health insurance giant and home ...

Dec 27 (Reuters) - Wall Street's holiday cheer ended abruptly on Friday, with all three main benchmarks slumping in a ...

Health-care companies fell as traders sought out sectors less vulnerable to shifting inflationary and demand trends.

Wall Street's holiday rally ends with major benchmarks slumping as tech and growth stocks decline. Rising U.S. Treasury ...

Optum and home health provider Amedisys have extended the deadline for their proposed $3.3 billion merger amid a legal challenge from the Department of Justice. Here are 10 things to know: 1. In a Dec ...

UnitedHealth Group (NYSE: UNH) and Amedisys (Nasdaq: AMED) have extended the deadline to finalize their merger agreement ...

Lamb Weston shares gained following reports activist investor Jana Partners took another step in its effort to force changes ...

Amedisys stock climbed Friday after the provider of home health care agreed to waive its right to terminate a merger ...